Case File
efta-efta01869445DOJ Data Set 10CorrespondenceEFTA Document EFTA01869445
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01869445
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey Epsteinfleevacation©gmail.com]
From:
Paul Tweed
Sent:
Wed 4/6/2011 8:45:04 AM
Subject: RE:
Noted Jeffrey. The press remain very sensitive about phone tapping and indeed privacy issues generally. We
do have the option to put the Mail on notice as per my earlier overview.
Kind regards.
Paul
Paul Tweed
Senior Partner
I JOHNSONS
Belfast I Dublin I London
t:
f:
m:
e:
w:
w‘vw.iohnsonslaw.com
b:
www.globallibeldebate.com
London Office
London, SW1A 1RN
Regulated by the Solicitors Regulation Authority
Firm SRA ID:
tittp://www sra.orq.ukfrules
EFTA_R1_00274188
EFTA01869445
Paul Tweed is also a member of Paul Tweed LLP
Regulated by the Solicitors Regulation Authority
SRA ID:
Disclaimer:
This e-mail transmission may be legally privileged but is, in any event, confidential and intended solely for the
person to whom it is addressed. If you are not the intended recipient, you must not copy, distribute or
disseminate the information in it, or take any action in reliance of it. Any views expressed in this message are
those of the individual sender, except where the sender specifically states them to be the views of Johnsons
Solicitors. If you have received this message in error, do not open any attachment, but please notify the
individual sender (above) deleting this message from your system. Please rely on your own virus check. While
reasonable efforts are made to ensure that e-mails are free from bugs or virus infection, no responsibility is
taken by Johnsons Solicitors for any damage arising from any bug or virus infection
From: Jeffrey Epstein [email protected]
Sent: 05 April 2011 21:10
To: Paul Tweed
Subject:
htto://www.nytimes.com/2011/04/06/worldieurooe/06britain. html7ho
The information contained in this communication is
confidential, may be attomey-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacatioragmail.com and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00274189
EFTA01869446
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jeevacatioragmail.comDomain
vw.iohnsonslaw.comDomain
www.globallibeldebate.comDomain
www.nytimes.comEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.